Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy

Ann N Y Acad Sci. 1995 Mar 27:752:115-27. doi: 10.1111/j.1749-6632.1995.tb17414.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin II / physiology
  • Animals
  • Cardiomegaly / drug therapy*
  • Cardiomegaly / physiopathology*
  • Endothelins / pharmacology
  • Endothelins / physiology
  • Endothelins / therapeutic use
  • Growth Substances / pharmacology
  • Growth Substances / physiology
  • Growth Substances / therapeutic use*
  • Heart / drug effects
  • Heart / growth & development
  • Heart / physiology*
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor I / physiology
  • Signal Transduction*
  • Transforming Growth Factor beta / pharmacology
  • Transforming Growth Factor beta / physiology

Substances

  • Endothelins
  • Growth Substances
  • Transforming Growth Factor beta
  • Angiotensin II
  • Insulin-Like Growth Factor I